SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon

Many African countries have reported relatively low numbers of COVID-19 cases but the true scale of the epidemic is unclear. Here, the authors conduct a population-based survey in a province of Cameroon and estimate 29% seroprevlance, >300 fold higher than the nationwide attack rate implied by ca...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kene Nwosu, Joseph Fokam, Franck Wanda, Lucien Mama, Erol Orel, Nicolas Ray, Jeanine Meke, Armel Tassegning, Desire Takou, Eric Mimbe, Beat Stoll, Josselin Guillebert, Eric Comte, Olivia Keiser, Laura Ciaffi
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/c0db4eec44b5484f96f1e8b55f5e0a91
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c0db4eec44b5484f96f1e8b55f5e0a91
record_format	dspace
spelling	oai:doaj.org-article:c0db4eec44b5484f96f1e8b55f5e0a912021-12-02T16:56:48ZSARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon10.1038/s41467-021-25946-02041-1723https://doaj.org/article/c0db4eec44b5484f96f1e8b55f5e0a912021-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25946-0https://doaj.org/toc/2041-1723Many African countries have reported relatively low numbers of COVID-19 cases but the true scale of the epidemic is unclear. Here, the authors conduct a population-based survey in a province of Cameroon and estimate 29% seroprevlance, >300 fold higher than the nationwide attack rate implied by case counts.Kene NwosuJoseph FokamFranck WandaLucien MamaErol OrelNicolas RayJeanine MekeArmel TassegningDesire TakouEric MimbeBeat StollJosselin GuillebertEric ComteOlivia KeiserLaura CiaffiNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-9 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Kene Nwosu Joseph Fokam Franck Wanda Lucien Mama Erol Orel Nicolas Ray Jeanine Meke Armel Tassegning Desire Takou Eric Mimbe Beat Stoll Josselin Guillebert Eric Comte Olivia Keiser Laura Ciaffi SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
description	Many African countries have reported relatively low numbers of COVID-19 cases but the true scale of the epidemic is unclear. Here, the authors conduct a population-based survey in a province of Cameroon and estimate 29% seroprevlance, >300 fold higher than the nationwide attack rate implied by case counts.
format	article
author	Kene Nwosu Joseph Fokam Franck Wanda Lucien Mama Erol Orel Nicolas Ray Jeanine Meke Armel Tassegning Desire Takou Eric Mimbe Beat Stoll Josselin Guillebert Eric Comte Olivia Keiser Laura Ciaffi
author_facet	Kene Nwosu Joseph Fokam Franck Wanda Lucien Mama Erol Orel Nicolas Ray Jeanine Meke Armel Tassegning Desire Takou Eric Mimbe Beat Stoll Josselin Guillebert Eric Comte Olivia Keiser Laura Ciaffi
author_sort	Kene Nwosu
title	SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
title_short	SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
title_full	SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
title_fullStr	SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
title_full_unstemmed	SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
title_sort	sars-cov-2 antibody seroprevalence and associated risk factors in an urban district in cameroon
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/c0db4eec44b5484f96f1e8b55f5e0a91
work_keys_str_mv	AT kenenwosu sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT josephfokam sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT franckwanda sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT lucienmama sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT erolorel sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT nicolasray sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT jeaninemeke sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT armeltassegning sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT desiretakou sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT ericmimbe sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT beatstoll sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT josselinguillebert sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT ericcomte sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT oliviakeiser sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon AT lauraciaffi sarscov2antibodyseroprevalenceandassociatedriskfactorsinanurbandistrictincameroon
_version_	1718382704031956992

SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon

Ejemplares similares